152 related articles for article (PubMed ID: 20700130)
1. α-MSH: a potential neuroprotective and immunomodulatory agent for the treatment of stroke.
Savos AV; Gee JM; Zierath D; Becker KJ
J Cereb Blood Flow Metab; 2011 Feb; 31(2):606-13. PubMed ID: 20700130
[TBL] [Abstract][Full Text] [Related]
2. Reduction of ischemic stroke in rat brain by alpha melanocyte stimulating hormone.
Chen G; Frøkiaer J; Pedersen M; Nielsen S; Si Z; Pang Q; Stødkilde-Jørgensen H
Neuropeptides; 2008 Jun; 42(3):331-8. PubMed ID: 18359516
[TBL] [Abstract][Full Text] [Related]
3. Alpha-MSH promotes spontaneous post-ischemic pneumonia in mice via melanocortin-receptor-1.
Schulte-Herbrüggen O; Quarcoo D; Brzoska T; Klehmet J; Meisel A; Meisel C
Exp Neurol; 2008 Apr; 210(2):731-9. PubMed ID: 18304533
[TBL] [Abstract][Full Text] [Related]
4. Plasma α-melanocyte stimulating hormone predicts outcome in ischemic stroke.
Zierath D; Tanzi P; Cain K; Shibata D; Becker K
Stroke; 2011 Dec; 42(12):3415-20. PubMed ID: 21960572
[TBL] [Abstract][Full Text] [Related]
5. Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury?
Becker K; Kindrick D; McCarron R; Hallenbeck J; Winn R
Stroke; 2003 Jul; 34(7):1809-15. PubMed ID: 12791945
[TBL] [Abstract][Full Text] [Related]
6. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.
Belayev L; Liu Y; Zhao W; Busto R; Ginsberg MD
Stroke; 2001 Feb; 32(2):553-60. PubMed ID: 11157196
[TBL] [Abstract][Full Text] [Related]
7. Niaspan treatment induces neuroprotection after stroke.
Shehadah A; Chen J; Zacharek A; Cui Y; Ion M; Roberts C; Kapke A; Chopp M
Neurobiol Dis; 2010 Oct; 40(1):277-83. PubMed ID: 20554037
[TBL] [Abstract][Full Text] [Related]
8. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
9. Alpha-melanocyte stimulating hormone suppresses intracerebral tumor necrosis factor-alpha and interleukin-1beta gene expression following transient cerebral ischemia in mice.
Huang Q; Tatro JB
Neurosci Lett; 2002 Dec; 334(3):186-90. PubMed ID: 12453626
[TBL] [Abstract][Full Text] [Related]
10. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat.
Li Q; Stephenson D
Exp Neurol; 2002 Oct; 177(2):531-7. PubMed ID: 12429198
[TBL] [Abstract][Full Text] [Related]
11. alpha-Melanocyte-stimulating hormone is neuroprotective in rat global cerebral ischemia.
Forslin Aronsson S; Spulber S; Popescu LM; Winblad B; Post C; Oprica M; Schultzberg M
Neuropeptides; 2006 Feb; 40(1):65-75. PubMed ID: 16414116
[TBL] [Abstract][Full Text] [Related]
12. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.
Hasegawa Y; Suzuki H; Sozen T; Rolland W; Zhang JH
Stroke; 2010 Feb; 41(2):368-74. PubMed ID: 19940275
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability.
Cui L; Zhang X; Yang R; Wang L; Liu L; Li M; Du W
Brain Res; 2010 Apr; 1325():164-73. PubMed ID: 20167207
[TBL] [Abstract][Full Text] [Related]
14. Cocaine-and amphetamine-regulated transcript modulates peripheral immunity and protects against brain injury in experimental stroke.
Chang L; Chen Y; Li J; Liu Z; Wang Z; Chen J; Cao W; Xu Y
Brain Behav Immun; 2011 Feb; 25(2):260-9. PubMed ID: 20869431
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective Effects of Chronic Fenofibrate Treatment via Modulating the Immunoreactivity of Cleaved Caspase-3 in Stroke Induced by Transient Middle Cerebral Artery Occlusion Rat Model.
Altintas O; Altintas MO; Aydin MS; Baran O; Antar V; Esrefoglu M; Asil T
Turk Neurosurg; 2017; 27(4):522-529. PubMed ID: 27509457
[TBL] [Abstract][Full Text] [Related]
16. Hyperbaric oxygenation and 20-hydroxyeicosatetreanoic acid inhibition reduce stroke volume in female diabetic Sprague-Dawley rats.
Mišir M; Renić M; Novak S; Mihalj M; Ćosić A; Vesel M; Drenjančević I
Exp Physiol; 2017 Dec; 102(12):1596-1606. PubMed ID: 28940693
[TBL] [Abstract][Full Text] [Related]
17. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.
Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P
J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191
[TBL] [Abstract][Full Text] [Related]
18. Intranasal wnt3a Attenuates Neuronal Apoptosis through Frz1/PIWIL1a/FOXM1 Pathway in MCAO Rats.
Matei N; Camara J; McBride D; Camara R; Xu N; Tang J; Zhang JH
J Neurosci; 2018 Jul; 38(30):6787-6801. PubMed ID: 29954850
[TBL] [Abstract][Full Text] [Related]
19. Delayed treatment with nicotinamide (Vitamin B(3)) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats.
Mokudai T; Ayoub IA; Sakakibara Y; Lee EJ; Ogilvy CS; Maynard KI
Stroke; 2000 Jul; 31(7):1679-85. PubMed ID: 10884473
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
Belayev L; Khoutorova L; Deisher TA; Belayev A; Busto R; Zhang Y; Zhao W; Ginsberg MD
Stroke; 2003 Mar; 34(3):758-63. PubMed ID: 12624304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
